In this study we report the first isolation of VanA-type vancomycin-resistant Enterococcus faecalis strains from two different patients hospitalized in the same intensive care unit at the hospital of Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, Minas Gerais, Brazil.
VRE isolation in hospitals has also increasing significantly, since the first report in 1998 (6) .
Glycopeptide resistance in enterococci is associated with a variety of phenotypes but VanA-type VRE is the most prevalent in Brazil (9) . VRE strains with this phenotype express high-level resistance to vancomycin and teicoplanin and harbored a mobile genetic element Tn1546 that carries vanA gene cluster responsible by glycopeptide resistance (5) .
In this study we report the first isolation of VanA-type VRE strains from two different patients hospitalized in the ICU at the hospital of the Universidade Federal do Triângulo Mineiro (UFTM), Uberaba, Minas Gerais, Brazil. Isolates were typed by pulsed-field gel electrophoresis (PFGE) after SmaI-digestion of DNA (2) in a Gene Navigator apparatus (Amersham, Uppsala, Sweden) at 180V for 25h, at 7ºC with pulses of 20s for 10h, 8s for 10h and 3s for 5h. DNA banding patterns were analysed using previously described criteria (12) .
Both VRE isolates were identified as Enterococcus faecalis and expressed high-level resistance to vancomycin (MIC ≥ 256 µg/ml). They showed the same antimicrobial susceptibility profile, characterized by resistance to ciprofloxacin, chloramphenicol, erythromycin, tetracycline and teicoplanin. The isolates showed susceptibility to ampicillin, penicillin, gentamicin and streptomycin.
According to multiplex PCR assay both VRE isolates harbored the vanA gene in the intact Tn1546-like element. The vanRSHAX genes were also detected by Long-PCR.
The molecular typing has disclosed the same PFGE pattern for both isolates (Fig. 1 In conclusion, our data showed that the VRE was transferred horizontally between patients in the same ICU room emphasizing that is very important to monitor their occurrence in hospital environment and to take measures to prevent the dissemination of nosocomial VRE among several patients. 
